Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

Market Cap	10.45B -14.4%
Revenue (ttm)	2.68B -7.8%
Net Income	204.33M +41.7%
EPS	0.25 +41.6%
Shares Out	824.60M
PE Ratio	51.16
Forward PE	32.08
Dividend	0.08 (0.64%)
Ex-Dividend Date	Apr 29, 2026

Volume	4,609,371
Average Volume	11,380,056
Open	12.56
Previous Close	12.67
Day's Range	12.56 - 12.85
52-Week Range	12.12 - 18.68
Beta	-0.08
RSI	37.51
Earnings Date	Apr 28, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,583
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002675

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.